Allison Jacob is a seasoned medical professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Senior Medical Director at Adaptive Biotechnologies Corp. since July 2015, Jacob has led the medical efforts for the company's first clinical diagnostic product and has played a pivotal role in US regulatory filings for minimal residual disease (MRD) diagnostics in blood cancers. Previous roles at Adaptive included Director of Medical Affairs and Director of Medical Science Liaisons, where leadership and strategic development of medical initiatives were key responsibilities. Prior to joining Adaptive, Jacob held roles at Amgen and Immunex, focusing on research and scientific liaison work in oncology and immunology. Jacob holds an MS in Molecular and Cellular Biology from the University of Washington and a BS in Biochemistry from Colorado State University.